Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 22, 2007
[Surgical treatment for gastroesophageal reflux disease (GERD)]Atsushi Iida, Akio YamaguchiOncology Reports|December 19, 2001
Heterogeneity of apoptosis and proliferative activity within superficial spreading type early gastric cancerHirofumi Awata, Kazuo Hirose, Akio YamaguchiAsian Journal of Endoscopic Surgery|April 23, 2013
Laparoscopic resection for splenic artery aneurysm using the lateral approach: report of two casesAtsushi Iida, Kanji Katayama, Akio YamaguchiCancer Science|August 11, 2022
Induction of immunogenic cell death in murine colon cancer cells by ferrocene-containing redox phospholipid polymersMasahiro Kaneko, Akio Yamaguchi, Akira ItoOncotarget|July 15, 2021
Prokineticin-1 induces normal lymphangiogenic activity and is involved in lymphangiogenesis and lymph node metastasis in colorectal cancerTakayuki Naruse, Takanori Goi, Akio YamaguchiAnticancer Research|December 11, 2013
Prokineticin 1 expression in gastrointestinal tumorsTakanori Goi, Toshiyuki Nakazawa, Yasuo Hirono, et al.International Surgery|November 12, 2010
The effectiveness of transverse coloplasty in patients with ultra-lower rectal cancerTakanori Goi, Kei Honda, Kanji Katayama, et al.Journal of Hepato-Biliary-Pancreatic Sciences|June 17, 2011
Effect of the silk protein sericin on cryopreserved rat isletsKenji Ohnishi, Makoto Murakami, Mitsuhiro Morikawa, et al.Oncotarget|August 31, 2015
The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1)Takanori Goi, Toshiyuki Nakazawa, Yasuo Hirono, et al.Annals of Surgical Oncology|May 20, 2014
Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancerTakanori Goi, Toshiyuki Nakazawa, Yasuo Hirono, et al.Pageof 10